UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 457

Sortiert nach

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

The New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300

2021

Volltextzugriff (PDF)

Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study

The lancet oncology, 2022-06, Vol.23 (6), p.768-780

2022

Volltextzugriff (PDF)

Extracorporeal shock wave therapy decreases COX‐2 by inhibiting TLR4‐NFκB pathway in a prostatitis rat model

The Prostate, 2019-09, Vol.79 (13), p.1498-1504

2019

Volltextzugriff (PDF)

Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial

International journal of cancer, 2023-09, Vol.153 (6), p.1241-1250

2023

Volltextzugriff (PDF)

Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate Cancer

International journal of molecular sciences, 2024-02, Vol.25 (5), p.2836

2024

Volltextzugriff (PDF)

Does increased body mass index lead to elevated prostate cancer risk? It depends on waist circumference

BMC cancer, 2020-06, Vol.20 (1), p.589-8, Article 589

2020

Volltextzugriff (PDF)

The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma

Journal of cancer research and clinical oncology, 2020-01, Vol.146 (1), p.187-196

2020

Volltextzugriff (PDF)

Deep learning for end-to-end kidney cancer diagnosis on multi-phase abdominal computed tomography

NPJ precision oncology, 2021-06, Vol.5 (1), p.54-54, Article 54

2021

Volltextzugriff (PDF)

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up

BMC cancer, 2020-12, Vol.20 (1), p.1203-9, Article 1203

2020

Volltextzugriff (PDF)

Effect of intraoperative fluid volume on postoperative ileus after robot-assisted radical cystectomy

Scientific reports, 2021-05, Vol.11 (1), p.10522-10522, Article 10522

2021

Volltextzugriff (PDF)

Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy

Scientific reports, 2021-02, Vol.11 (1), p.3079-3079, Article 3079

2021

Volltextzugriff (PDF)

Engineered Mesenchymal Stem Cells Expressing Stromal Cell-derived Factor-1 Improve Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats

International journal of molecular sciences, 2018-11, Vol.19 (12), p.3730

2018

Volltextzugriff (PDF)

Partial Correlation Analysis and Neural-Network-Based Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy

Applied sciences, 2023-01, Vol.13 (2), p.891

2023

Volltextzugriff (PDF)

The impact of Hounsfield unit-related variables on percutaneous nephrolithotomy outcomes

Scientific reports, 2022-11, Vol.12 (1), p.18451-18451, Article 18451

2022

Volltextzugriff (PDF)

Use of artificial intelligence to characterize renal tumors

Investigative and Clinical Urology, 2022, 63(2), , pp.123-125

2022

Volltextzugriff (PDF)

Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study

Scientific reports, 2024-02, Vol.14 (1), p.4740-4740, Article 4740

2024

Volltextzugriff (PDF)

Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status

Scientific reports, 2018-01, Vol.8 (1), p.947-7, Article 947

2018

Volltextzugriff (PDF)

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy

BMC cancer, 2017-05, Vol.17 (1), p.364-364, Article 364

2017

Volltextzugriff (PDF)

Machine-Learning-Based Digital Twin System for Predicting the Progression of Prostate Cancer

Applied sciences, 2022-08, Vol.12 (16), p.8156

2022

Volltextzugriff (PDF)

Development and Validation of a Prediction Model for Differentiation of Benign and Malignant Fat-Poor Renal Tumors Using CT Radiomics

Applied sciences, 2023-10, Vol.13 (20), p.11345

2023

Volltextzugriff (PDF)

Association of body mass index with bladder cancer risk in men depends on abdominal obesity

World journal of urology, 2019-11, Vol.37 (11), p.2393-2400

2019

Volltextzugriff (PDF)

Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database

Journal of Korean Medical Science, 2024, 39(3), , pp.1-9

2024

Volltextzugriff (PDF)

Engineered Stem Cells Improve Neurogenic Bladder by Overexpressing SDF-1 in a Pelvic Nerve Injury Rat Model

Cell transplantation, 2020-01, Vol.29, p.963689720902466-963689720902466

2020

Volltextzugriff (PDF)

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma

Frontiers in oncology, 2019-09, Vol.9, p.859-859

2019

Volltextzugriff (PDF)

Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel

Cancers, 2024-06, Vol.16 (11), p.2006

2024

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Aktive Filter

ThemaSurgery

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(390)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study

Extracorporeal shock wave therapy decreases COX‐2 by inhibiting TLR4‐NFκB pathway in a prostatitis rat model

Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial

Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate Cancer

Does increased body mass index lead to elevated prostate cancer risk? It depends on waist circumference

The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma

Deep learning for end-to-end kidney cancer diagnosis on multi-phase abdominal computed tomography

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up

Effect of intraoperative fluid volume on postoperative ileus after robot-assisted radical cystectomy

Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy

Engineered Mesenchymal Stem Cells Expressing Stromal Cell-derived Factor-1 Improve Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats

Partial Correlation Analysis and Neural-Network-Based Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy

The impact of Hounsfield unit-related variables on percutaneous nephrolithotomy outcomes

Use of artificial intelligence to characterize renal tumors

Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study

Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy

Machine-Learning-Based Digital Twin System for Predicting the Progression of Prostate Cancer

Development and Validation of a Prediction Model for Differentiation of Benign and Malignant Fat-Poor Renal Tumors Using CT Radiomics

Association of body mass index with bladder cancer risk in men depends on abdominal obesity

Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database

Engineered Stem Cells Improve Neurogenic Bladder by Overexpressing SDF-1 in a Pelvic Nerve Injury Rat Model

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma

Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel

Aktive Filter

Suchergebnisse filtern